Breakout Sessions

The AI Wild West: Bringing Governance to Benefits

AI is already making decisions that shape employee benefits—but governance hasn’t caught up. In this provocative panel, leaders from Mercer, Vertex, and The Hartford debate who really owns AI decisions, where the biggest unseen risks are, who’s accountable when outcomes go wrong, and what the future of AI looks like. A must‑attend conversation for employers who don’t want AI risk to become their next benefits crisis.

From Noise to Insight: How AI Helps You Hear—and Act on—What Your Health Plan Is Saying

This session is built for CFOs, HR and Benefits leaders, and risk/finance partners who are accountable for health plan performance but frustrated by opaque cost drivers. You’ll learn how AI can surface the real drivers behind spend—trend vs. utilization, condition prevalence, site of care, and leakage—and translate them into clear, actionable decisions.

 We’ll show practical ways to move from insight to intervention, including where to focus first for measurable savings. Expect real examples of how employers are using these insights to improve outcomes and control costs without guesswork.

Your Guide to Navigate the Political Noise

As the workforce adapts to increasing longevity and the rapid evolution of AI, employee benefits professionals must rethink traditional models to stay ahead. This dynamic session will explore how demographic shifts, caregiving responsibilities, smart technology, and AI-driven decision-making are shaping the future of work and employee benefits.

Learn how employees seek financial guidance, how caregiving is becoming a workplace norm, and how AI is influencing related HR practices—from recruitment to benefits customization.

This session will provide a roadmap for HR and benefits leaders to navigate an aging workforce, embrace strategic tools, and design benefits programs that align with the needs of a longer-living, evolving workforce.

Gene and Cellular Therapies: The Cost of Changing Lives

Financing breakthrough gene therapies is no longer a distant question—it’s an urgent, strategic issue for employers. This session will decode what’s coming, what it means for your health plan, and how HR leaders can unlock life-changing cures for employees while protecting the bottom line. Cellular therapies use living cells (often taken from a patient or a donor and changed or grown in a lab) to fight disease, while gene therapies change a person’s genes (for example, by fixing a faulty gene) to treat or prevent illness—both can be powerful but work in very different ways and have different costs and care needs. Hear experts break down the latest trends in gene therapy, innovative benefit designs, and stop loss strategies that help manage volatility and mitigate catastrophic risk. You’ll leave with a clear, practical roadmap to balance innovation, affordability, and sustainability—so your organization is ready for the future of care.

Invisible Second Shift: Mental Health on Caregiver Island 

  • Jennifer Fraone

    Strategic Advisor

    Jennifer Sabatini Fraone Consulting, LLC

    Read Bio

  • Evan Falchuck

    CEO

    Family First

    Read Bio

Cybersecurity

  • Casey Cullinan Schepers

    Head of Norton Lifelock Benefit Solutions

    Norton Lifelock

    Read Bio